Virdante Pharmaceuticals is a biopharmaceutical company that develops and commercializes drugs for autoimmune and inflammatory diseases.
Business Model:
Revenue: $0
Employees: 11-50
Virdante Pharmaceuticals was acquired by
Momenta Pharmaceuticals.
The acquisition happend on 2011-12-05.
Details of the transaction were not public
Address: 101 Main St
City: Cambridge
State: MA
Zip: 02142
Country: US
Virdante Pharmaceuticals is a biopharmaceutical company that develops and commercializes drugs for autoimmune and inflammatory diseases.
Contact Phone:
+16173008500
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2011 | Venture Round | $30.1M | 10/2009 | Series A | $47.8M |
Thomas, McNerney & Partners Venrock MedImmune Ventures, Inc. Osage Partners Clarus Ventures |
11/2009 | Series A | 6 | $30M |
Biogen Idec Clarus Ventures MedImmune Ventures OUP (Osage University Partners) Thomas, McNerney &a; Partners Venrock Biogen Idec Clarus Ventures MedImmune Ventures OUP (Osage University Partners) Thomas, McNerney &a; Partners Venrock |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|